DNAvisit Company Profile

Background

DNAvisit, established in 2017 and headquartered in San Diego, California, is a pioneering telegenomics company dedicated to integrating genetic counseling into healthcare through advanced technology. The company's mission is to enhance patient care by seamlessly incorporating genomics into clinical workflows, thereby unlocking the full potential of genetic information in medical practice. By leveraging a technology-driven approach, DNAvisit aims to provide high-quality, cost-effective genetic counseling services that are both accessible and efficient.

Key Strategic Focus

DNAvisit's strategic focus centers on delivering scalable and flexible genetic counseling solutions that can be rapidly integrated into various healthcare settings. The company specializes in areas such as cancer genetics, pharmacogenomics, reproductive genetics, cardiac genetics, adult and pediatric genetics, neurogenetics, and whole genome and exome sequencing. Utilizing proprietary technologies like the Genetic Counseling Studio™, DNAvisit offers HIPAA-compliant platforms that facilitate seamless communication between genetic counselors, pharmacists, patients, and healthcare providers. Their primary markets include genetic testing laboratories, health organizations, digital health companies, biopharmaceutical organizations, and clinical research entities.

Financials and Funding

Since its inception, DNAvisit has experienced significant growth. The company participated in the Y Combinator accelerator program in 2017, which provided initial funding and support. In 2020, DNAvisit reported rapid adoption of its services, working with numerous healthcare organizations, clinical labs, and employers across the United States. The company has been cash flow positive since its early stages, indicating a sustainable business model.

Technological Platform and Innovation

DNAvisit distinguishes itself through its proprietary Genetic Counseling Studio™, a platform that integrates AI-enhanced tools to support genetic counselors and pharmacists. This platform offers features such as smart scheduling, AI-powered medical records review, and HIPAA-compliant communication channels, including phone, video, and digital chat. The company's technology facilitates efficient patient identification, medical data integration, and ongoing monitoring through its Health AI Studio, which provides insights from patients' medical records using predefined prompts tailored to specific use cases.

Leadership Team

DNAvisit's leadership comprises experienced professionals with diverse backgrounds:

Ahmed El-kalliny, MS, MBA: Founder and Chief Executive Officer. Ahmed has a background in biomedical engineering and bioengineering, with experience in market development and product management at Thermo Fisher Scientific.

Jaime Barea, MD, FACMG: Co-Founder and Chief Medical Officer. Jaime is a board-certified medical geneticist with extensive experience in clinical genetics.

Archil Kublashvili, MS: Co-Founder and Chief Technology Officer. Archil brings expertise in technology development and implementation within the healthcare sector.

Heather Wetzel, MS, LCGC: Director of Genetic Counseling. Heather is a licensed genetic counselor with over a decade of experience in various genetic counseling domains.

Competitor Profile

Market Insights and Dynamics

The genetic counseling market is experiencing rapid growth, driven by advancements in genomics and increasing demand for personalized medicine. The global DNA testing market is projected to reach $25 billion by 2025, with genetic counseling services expected to grow correspondingly.

Competitor Analysis

DNAvisit operates in a competitive landscape alongside companies such as:

Genetics Maven: Offers genetic counseling services with a focus on personalized patient care.

Navigate Genetic Counseling: Provides comprehensive genetic counseling solutions for various healthcare providers.

JScreen: Specializes in genetic screening and counseling services, particularly in the context of reproductive health.

FiND Genetics: Focuses on delivering genetic counseling and testing services with an emphasis on rare diseases.

San Francisco Genetic Counseling: Offers a range of genetic counseling services tailored to individual patient needs.

These competitors vary in their service offerings, technological integration, and target markets, contributing to a dynamic and evolving industry landscape.

Strategic Collaborations and Partnerships

In January 2020, DNAvisit partnered with Scripps Research to incorporate its AI-enabled platform into a polygenic risk study. This collaboration aimed to enhance genetic counseling services for research participants, demonstrating DNAvisit's commitment to advancing precision medicine through strategic alliances.

Operational Insights

DNAvisit's technology-driven approach offers distinct competitive advantages, including scalability, flexibility, and cost-effectiveness. The company's platform is designed to handle projects ranging from tens to thousands of patients per month, catering to a wide range of clients, from small clinics to large healthcare organizations. By integrating AI and maintaining HIPAA compliance, DNAvisit ensures high-quality service delivery while adhering to regulatory standards.

Strategic Opportunities and Future Directions

Looking ahead, DNAvisit aims to expand its population health programs, with plans to scale from current pilot projects to partnerships with hundreds of employers. The company also seeks to grow its client base among clinical labs and healthcare providers, further solidifying its position in the genetic counseling market. By continuing to innovate and adapt to the evolving healthcare landscape, DNAvisit is well-positioned to capitalize on the increasing demand for genetic counseling services.